Psychiatry News: MDMA Therapy May Reduce Eating Disorder Symptoms.
Study finds MDMA-assisted psychotherapy could help relieve PTSD
JCM | Free Full-Text | MDMA for the Treatment of Negative Symptoms in Schizophrenia
JCM | Free Full-Text | MDMA for the Treatment of Negative Symptoms in Schizophrenia
Quetiapine | Atypical Antipsychotic Use & Side Effects | YoungMinds
These pills are meant to cure your comedown. Science begs to differ | WIRED UK
Characterization of 3,4-Methylenedioxymethamphetamine (MDMA) Enantiomers In Vitro and in the MPTP-Lesioned Primate: R-MDMA Reduces Severity of Dyskinesia, Whereas S-MDMA Extends Duration of ON-Time | Journal of Neuroscience
MDMA (XTC, E, ecstasy) party drug molecule. Full chemical name is 3,4-methylenedioxymethamphetamine. Skeletal formula. - NeuRA Library
MDMA (XTC, E, ecstasy) party drug molecule. Full chemical name is 3,4-methylenedioxymethamphetamine. Skeletal formula. - NeuRA Library
First study of safety and tolerability of 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy in patients with alcohol use disorder: preliminary data on the first four participants | BMJ Case Reports
Frontiers | Using a MDMA- and LSD-Group Therapy Model in Clinical Practice in Switzerland and Highlighting the Treatment of Trauma-Related Disorders
3,4-Methylenedioxymethamphetamine (Ecstasy) Inhibits Dyskinesia Expression and Normalizes Motor Activity in 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Treated Primates | Journal of Neuroscience
Side Effects of Seroquel (Quetiapine) | Greenhouse
3,4-Methylenedioxymethamphetamine (Ecstasy) Inhibits Dyskinesia Expression and Normalizes Motor Activity in 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Treated Primates | Journal of Neuroscience
Overdose Profile: Cocaine & Ecstasy Signs and Symptoms | PBI
Characterization of 3,4-Methylenedioxymethamphetamine (MDMA) Enantiomers In Vitro and in the MPTP-Lesioned Primate: R-MDMA Reduces Severity of Dyskinesia, Whereas S-MDMA Extends Duration of ON-Time | Journal of Neuroscience
Characterization of 3,4-Methylenedioxymethamphetamine (MDMA) Enantiomers In Vitro and in the MPTP-Lesioned Primate: R-MDMA Reduces Severity of Dyskinesia, Whereas S-MDMA Extends Duration of ON-Time | Journal of Neuroscience
Full article: Neurotoxicity of drugs of abuse - the case of methylenedioxy amphetamines (MDMA, ecstasy ), and amphetamines
Pill Library - Know Your Stuff NZ
Quetiapine drug deaths England & Wales 2021 | Statista
Signs of Seroquel Abuse - Greenhouse Treatment Center
3,4-Methylenedioxymethamphetamine (Ecstasy) Inhibits Dyskinesia Expression and Normalizes Motor Activity in 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Treated Primates | Journal of Neuroscience
Characterization of 3,4-Methylenedioxymethamphetamine (MDMA) Enantiomers In Vitro and in the MPTP-Lesioned Primate: R-MDMA Reduces Severity of Dyskinesia, Whereas S-MDMA Extends Duration of ON-Time | Journal of Neuroscience
Characterization of 3,4-Methylenedioxymethamphetamine (MDMA) Enantiomers In Vitro and in the MPTP-Lesioned Primate: R-MDMA Reduces Severity of Dyskinesia, Whereas S-MDMA Extends Duration of ON-Time | Journal of Neuroscience
MDMA related drug deaths England & Wales 2021 | Statista
MDMA ecstasy concept chemical formula icon label, text font vector illustration, isolated on white. Periodic element table, addictive drug. - NeuRA Library
Characterization of 3,4-Methylenedioxymethamphetamine (MDMA) Enantiomers In Vitro and in the MPTP-Lesioned Primate: R-MDMA Reduces Severity of Dyskinesia, Whereas S-MDMA Extends Duration of ON-Time | Journal of Neuroscience
